LEGN
Legend Biotech

976
Mkt Cap
$4.33B
Volume
1,032.00
52W High
$45.30
52W Low
$20.21
PE Ratio
-17.93
LEGN Fundamentals
Price
$23.42
Prev Close
$22.14
Open
$21.70
50D MA
$25.27
Beta
0.59
Avg. Volume
2.3M
EPS (Annual)
-$0.9686
P/B
4.28
Rev/Employee
$240,534.92
Loading...
Loading...
News
all
press releases
Royal Bank Of Canada Reiterates "Outperform" Rating for Legend Biotech (NASDAQ:LEGN)
Royal Bank Of Canada reaffirmed an "outperform" rating and set a $66.00 price objective on shares of Legend Biotech in a research note on Tuesday...
MarketBeat·18h ago
News Placeholder
More News
News Placeholder
Legend Biotech (NASDAQ:LEGN) Rating Increased to Strong-Buy at Jefferies Financial Group
Jefferies Financial Group raised Legend Biotech to a "strong-buy" rating in a research report on Monday...
MarketBeat·24h ago
News Placeholder
Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Given Consensus Rating of "Moderate Buy" by Analysts
Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the twelve research firms that are covering the firm...
MarketBeat·2d ago
News Placeholder
Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Short Interest Up 23.3% in December
Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN - Get Free Report) was the recipient of a significant increase in short interest during the month of December. As of December 31st, there was...
MarketBeat·2d ago
News Placeholder
Legend Biotech (NASDAQ:LEGN) Reaches New 12-Month Low - What's Next?
Legend Biotech (NASDAQ:LEGN) Hits New 52-Week Low - Here's What Happened...
MarketBeat·16d ago
News Placeholder
Legend Biotech Corporation Sponsored ADR $LEGN Shares Sold by Matthews International Capital Management LLC
Matthews International Capital Management LLC trimmed its holdings in Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN - Free Report) by 20.5% during the third quarter, according to the company...
MarketBeat·24d ago
News Placeholder
Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Given Consensus Recommendation of "Moderate Buy" by Analysts
Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN - Get Free Report) has been assigned an average rating of "Moderate Buy" from the twelve brokerages that are covering the company, MarketBeat...
MarketBeat·27d ago
News Placeholder
Squarepoint Ops LLC Grows Stock Position in Legend Biotech Corporation Sponsored ADR $LEGN
Squarepoint Ops LLC raised its holdings in shares of Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN - Free Report) by 77.6% in the 2nd quarter, according to its most recent 13F filing with the...
MarketBeat·1mo ago
News Placeholder
Stempoint Capital LP Takes $9.59 Million Position in Legend Biotech Corporation Sponsored ADR $LEGN
Stempoint Capital LP bought a new position in shares of Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F...
MarketBeat·1mo ago
News Placeholder
Legend Biotech (NASDAQ:LEGN) Trading Down 4.7% - Time to Sell?
Legend Biotech (NASDAQ:LEGN) Stock Price Down 4.7% - Time to Sell...
MarketBeat·1mo ago
<
1
2
...
>

Latest LEGN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.